Related Experiment Video
Updated: Oct 1, 2025
Quantifying the Antifungal Activity of Peptides Against Candida albicans
Published on: January 13, 2023
Small molecule based anti-virulence approaches against Candida albicans infections
Shanthini Kalimuthu1, Om Alkhir Alshanta2, Akshaya Lakshmi Krishnamoorthy1,3
1Faculty of Dentistry, The University of Hong Kong, Hong Kong, China.
Abstract:
Fungi are considered "silent killers" due to the difficulty of, and delays in diagnosis of infections and lack of effective antifungals. This challenge is compounded by the fact that being eukaryotes, fungi share several similarities with human cellular targets, creating obstacles to drug discovery. Candida albicans, a ubiquitous microbe in the human body is well-known for its role as an opportunistic pathogen in immunosuppressed people. Significantly, C. albicans is resistant to all the three classes of antifungals that are currently clinically available. Over the past few years, a paradigm shift has been recommended in the management of C. albicans infections, wherein anti-virulence strategies are considered an alternative to the discovery of new antimycotics. Small molecules, with a molecular weight <900 Daltons, can easily permeate the cell membrane and modulate the signal transduction pathways to elicit desired virulence inhibitory actions against pathogens. This review dissects in-depth, the discoveries that have been made with small-molecule anti-virulence approaches to tackle C. albicans infections.
Insights
Fungal infections like Candida albicans are hard to treat due to drug resistance. Anti-virulence strategies using small molecules offer a promising alternative to traditional antifungal drugs.
Area of Science:
- Microbiology and Mycology
- Infectious Diseases
- Pharmacology
Background:
- Fungal infections, particularly from Candida albicans, pose significant health risks due to diagnostic challenges and antifungal resistance.
- Candida albicans is an opportunistic pathogen resistant to current antifungal therapies, necessitating novel treatment strategies.
- Eukaryotic similarities between fungi and human cells complicate the development of targeted antifungal drugs.
Approach:
- This review explores anti-virulence strategies as an alternative to direct antifungal drug discovery.
- Focuses on small molecules (<900 Daltons) capable of cell membrane permeation.
- Investigates how small molecules modulate fungal signal transduction pathways to inhibit virulence.
Key Points:
- Anti-virulence strategies offer a new paradigm for managing Candida albicans infections.
- Small molecules can disrupt fungal virulence mechanisms without directly killing the fungus.
- Targeting virulence factors may overcome existing drug resistance.
Conclusions:
- Small-molecule anti-virulence approaches represent a promising avenue for combating challenging fungal infections.
- This strategy may reduce the selective pressure for resistance development compared to traditional antifungals.
- Further research into small-molecule modulators of virulence is crucial for developing effective therapies.
